Tsp Capital Management Group, LLC Celldex Therapeutics, Inc. Transaction History

Tsp Capital Management Group, LLC

$264 Million
Q4 2024

A detailed history of Tsp Capital Management Group, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Tsp Capital Management Group, LLC holds 223,343 shares of CLDX stock, worth $5.28 Million. This represents 2.14% of its overall portfolio holdings.

Number of Shares

223,343

Previous 247,820 9.88%

Holding current value

$5.28 Million

Previous $8.42 Million 32.97%

% of portfolio

2.14%

Previous 2.89%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	SELL	$23.31 - $32.4 $570,558 - $793,054	-24,477 Reduced 9.88%	223,343 $5.64 Million
Q3 2024 Oct 15, 2024	SELL	$32.06 - $44.56 $44,884 - $62,384	-1,400 Reduced 0.56%	247,820 $8.42 Million
Q1 2024 Apr 30, 2024	SELL	$35.22 - $51.88 $80,125 - $118,027	-2,275 Reduced 0.9%	249,220 $10.5 Million
Q4 2023 Jan 16, 2024	SELL	$22.61 - $40.65 $4,522 - $8,130	-200 Reduced 0.08%	251,495 $9.97 Million
Q3 2023 Nov 07, 2023	SELL	$25.45 - $37.46 $5,090 - $7,492	-200 Reduced 0.08%	251,695 $6.93 Million
Q2 2023 Jul 19, 2023	SELL	$30.29 - $38.28 $15,145 - $19,140	-500 Reduced 0.2%	251,895 $8.55 Million
Q1 2023 Apr 13, 2023	SELL	$34.78 - $47.43 $608,650 - $830,025	-17,500 Reduced 6.48%	252,395 $9.08 Million
Q4 2022 Jan 17, 2023	BUY	$27.78 - $45.38 $72,228 - $117,988	2,600 Added 0.97%	269,895 $0
Q3 2022 Oct 20, 2022	BUY	$22.7 - $37.57 $17,025 - $28,177	750 Added 0.28%	267,295 $7.51 Million
Q2 2022 Jul 21, 2022	SELL	$20.5 - $37.33 $51,250 - $93,325	-2,500 Reduced 0.93%	266,545 $7.19 Million
Q1 2022 May 12, 2022	BUY	$27.64 - $39.32 $424,246 - $603,522	15,349 Added 6.05%	269,045 $9.16 Million
Q4 2021 Jan 26, 2022	SELL	$35.68 - $56.27 $632,713 - $997,835	-17,733 Reduced 6.53%	253,696 $9.8 Million
Q3 2021 Nov 03, 2021	SELL	$28.95 - $55.99 $1.98 Million - $3.84 Million	-68,500 Reduced 20.15%	271,429 $14.7 Million
Q2 2021 Aug 13, 2021	SELL	$20.71 - $35.37 $399,703 - $682,641	-19,300 Reduced 5.37%	339,929 $11.4 Million
Q1 2021 Apr 16, 2021	SELL	$16.19 - $29.91 $712,360 - $1.32 Million	-44,000 Reduced 10.91%	359,229 $7.4 Million
Q4 2020 Feb 03, 2021	SELL	$14.99 - $22.75 $577,115 - $875,875	-38,500 Reduced 8.72%	403,229 $7.07 Million
Q3 2020 Oct 14, 2020	BUY	$9.65 - $15.19 $711,861 - $1.12 Million	73,768 Added 20.05%	441,729 $6.55 Million
Q2 2020 Jul 22, 2020	SELL	$1.61 - $13.41 $67,710 - $563,970	-42,056 Reduced 10.26%	367,961 $4.78 Million
Q1 2020 Apr 23, 2020	BUY	$1.55 - $3.07 $82,346 - $163,099	53,127 Added 14.89%	410,017 $681,000
Q4 2019 Jan 17, 2020	BUY	$2.11 - $2.8 $406,698 - $539,694	192,748 Added 117.43%	356,890 $796,000
Q3 2019 Nov 14, 2019	BUY	$2.05 - $2.75 $18,575 - $24,917	9,061 Added 5.84%	164,142 $350,000
Q2 2019 Aug 09, 2019	SELL	$2.43 - $5.09 $3,239 - $6,784	-1,333 Reduced 0.85%	155,081 $416,000
Q1 2019 May 14, 2019	BUY	$3.45 - $10.35 $539,628 - $1.62 Million	156,414 New	156,414 $770,000

Others Institutions Holding CLDX

# of Institutions

198

Shares Held

65.9M

Call Options Held

1.68M

Put Options Held

980K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.11B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tsp Capital Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tsp Capital Management Group, LLC with notifications on news.

Account

Tsp Capital Management Group, LLC Celldex Therapeutics, Inc. Transaction History